1. Home
  2. BLNK vs ELTX Comparison

BLNK vs ELTX Comparison

Compare BLNK & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLNK
  • ELTX
  • Stock Information
  • Founded
  • BLNK 2009
  • ELTX 2011
  • Country
  • BLNK United States
  • ELTX United States
  • Employees
  • BLNK N/A
  • ELTX N/A
  • Industry
  • BLNK Industrial Specialties
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLNK Consumer Discretionary
  • ELTX Health Care
  • Exchange
  • BLNK Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • BLNK 129.3M
  • ELTX 121.7M
  • IPO Year
  • BLNK N/A
  • ELTX N/A
  • Fundamental
  • Price
  • BLNK $1.36
  • ELTX $11.50
  • Analyst Decision
  • BLNK Buy
  • ELTX Strong Buy
  • Analyst Count
  • BLNK 8
  • ELTX 2
  • Target Price
  • BLNK $2.54
  • ELTX $11.00
  • AVG Volume (30 Days)
  • BLNK 3.4M
  • ELTX 101.1K
  • Earning Date
  • BLNK 11-06-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • BLNK N/A
  • ELTX N/A
  • EPS Growth
  • BLNK N/A
  • ELTX N/A
  • EPS
  • BLNK N/A
  • ELTX N/A
  • Revenue
  • BLNK $104,788,000.00
  • ELTX N/A
  • Revenue This Year
  • BLNK N/A
  • ELTX N/A
  • Revenue Next Year
  • BLNK $19.30
  • ELTX N/A
  • P/E Ratio
  • BLNK N/A
  • ELTX N/A
  • Revenue Growth
  • BLNK N/A
  • ELTX N/A
  • 52 Week Low
  • BLNK $0.63
  • ELTX $4.05
  • 52 Week High
  • BLNK $2.32
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • BLNK 70.55
  • ELTX 56.79
  • Support Level
  • BLNK $1.28
  • ELTX $10.00
  • Resistance Level
  • BLNK $1.44
  • ELTX $11.89
  • Average True Range (ATR)
  • BLNK 0.11
  • ELTX 0.71
  • MACD
  • BLNK 0.03
  • ELTX -0.05
  • Stochastic Oscillator
  • BLNK 81.40
  • ELTX 57.25

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: